AI assistant
Abrdn PLC — Share Issue/Capital Change 2020
Apr 17, 2020
4853_sha_2020-04-17_de08063d-7852-4d36-8195-b6b92b8393c7.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 0699K
Standard Life Aberdeen plc
17 April 2020
BLOCK LISTING SIX MONTHLY RETURN
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 17 April 2020
| Name of applicant: | Standard Life Aberdeen plc | |||
| Name of scheme: | The Standard Life Share Plan | |||
| Period of return: | From: | 19/10/2019 | To: | 17/04/2020 |
| Balance of unallotted securities under scheme(s) from previous return: | 306,322 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 899 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 305,423 | |||
| Name of applicant: | Standard Life Aberdeen plc | |||
| Name of scheme: | The Standard Life Sharesave Plan | |||
| Period of return: | From: | 19/10/2019 | To: | 17/04/2020 |
| Balance of unallotted securities under scheme(s) from previous return: | 245,294 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | - | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 245,294 | |||
| Name of contact: | Paul McKenna |
| Telephone number of contact: | 0131 372 0703 |
LEI: OTMBS544NMO7GLCE7H90
3.1.Additional regulated information required to be disclosed under the laws of a Member State
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BLRGPUQACUPUGGM